Kura Oncology’s ziftomenib addresses a specific genetic mutation present in about 30% of cases of acute myeloid leukemia. Data from the drug’s pivotal Phase 2 test were presented during the annual meeting of the American Society of Clinical Oncology. The post Kura Oncology Drug’s Data at ASCO Support FDA Filing Now Under Priority Review for…
Acquiring FarmboxRx will help Pyx Health tackle food insecurity, a challenge many of its members struggle with. The post Pyx Health Acquires FarmboxRx With $47.5M Funding Boost appeared first on MedCity News.
This is the moment to build flexible plans. Organizations that develop operational models with built-in scenario planning, ready to scale up or down as the capital environment shifts, will be positioned to take advantage of greater investment when it comes. The post Weathering the Shifting Trial Landscape appeared first on MedCity News.
The combination of coverage awareness and care navigation powered by agentic AI has the potential to transform how older adults engage with the healthcare system. The post The Age of Action: Seizing CMS’s Call to Reimagine Medicare appeared first on MedCity News.
Bristol Myers Squibb’s partnership with BioNTech makes it the third big pharma company to strike a deal to gain access to a PD-L1/PD-1 and VEGF bispecific antibody with potential use in drug combinations to treat cancer. The deal calls for the two companies to share in the development of BioNTech’s drug and co-commercialize the asset…
Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes. The post How One Startup Is Aiming to Replace Surgery…
Wisp is now offering at-home testing for Chlamydia, Gonorrhea, Trichomaniasis and Mycoplasma Genitalium. The post Wisp Unveils Diagnostics Arm appeared first on MedCity News.
At Compass One Healthcare, sustainable practices are embedded in everything we do. Once again, we’re proud to celebrate that many of our hospital partners have been recognized with 2025 Practice Greenhealth Environmental Excellence Awards, including honors like the Circles of Excellence, Greenhealth Emerald, and Partner for Change Awards. These awards are more than just recognition, they’re a reflection of…
The “One Big Beautiful Bill” would codify Individual Coverage Health Reimbursement Arrangements (ICHRAs) — the personalized insurance model that has transformed how employers offer health benefits — into law as CHOICE Arrangements, or Custom Health Option and Individual Care Expense arrangements. The post A Defining Moment for Employer Health Benefits: How the “One Big Beautiful…
The bottom line is that while recognizing there is an issue is vital, too many healthcare organizations are counting on solutions that cannot and will not provide a sufficient line of defense. The post HIPAA’s Blind Spot: It’s Time to Address Client-Side Attacks appeared first on MedCity News.